Immunome, Inc. (NASDAQ:IMNM) is among the 14 champion booming stocks to bargain close now. The company’s shares are surging and person gained 48% successful the past 3 months.
Stock marketplace information showing an upward trajectory. Photo by Burak The Weekender connected Pexels
The returns person been driven chiefly by bullish outlooks connected the stock’s imaginable to dainty desmoid tumors.
On December 15, Immunome, Inc. (NASDAQ:IMNM) shared affirmative topline results from the Phase 3 RINGSIDE trial, demonstrating an improved endurance complaint without progression, erstwhile compared with a placebo. The results showed the cause decreased the likelihood of decease oregon illness progression by 84%.
According to the company’s property release, 156 patients were portion of the trial, of which astir 56% of them had their tumors vanish oregon shrink successful size, successful opposition with 9% connected placebo. Based connected the results, Immunome, Inc. (NASDAQ:IMNM) said it plans connected seeking support from the FDA for Varegacestat successful the 2nd 4th of 2026.
Following the results, Guggenheim, connected December 22, revised its terms people connected the banal to $35 from $25, portion keeping a Buy standing connected the shares. The probe steadfast expects support for Varegacestat from the FDA and says the cause could drawback a large chunk of the stock successful America’s desmoid tumors market.
Evercore ISI Group and Lake Street besides lifted their terms targets connected Immunome, Inc. (NASDAQ:IMNM) to $40 from $18, and $32 from $22, portion reiterating their Outperform and Buy ratings, respectively.
Wall Street analysts person a statement Strong Buy standing connected the stock, with a one-year mean stock terms people of $33.20, representing an upside imaginable of 61.40%, arsenic of January 12.
Immunome, Inc. (NASDAQ:IMNM) is an oncology institution that develops treatments and therapies for crab patients.
While we admit the imaginable of IMNM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 14 Best S&P 500 Stocks to Buy Now and 11 Most Oversold S&P 500 Stocks Heading into 2026
Disclosure: None.

2 days ago
3



.png)

English (CA) ·
English (US) ·
Spanish (MX) ·